- Home
- PGRE vs OMCL Comparison
PGRE vs OMCL Comparison
Compare PGRE & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGRE
- OMCL
- Stock Information
- Founded
- PGRE 1978
- OMCL 1992
- Country
- PGRE United States
- OMCL United States
- Employees
- PGRE N/A
- OMCL N/A
- Industry
- PGRE Real Estate Investment Trusts
- OMCL Computer Manufacturing
- Sector
- PGRE Real Estate
- OMCL Technology
- Exchange
- PGRE Nasdaq
- OMCL Nasdaq
- Market Cap
- PGRE 1.3B
- OMCL 1.3B
- IPO Year
- PGRE 2014
- OMCL 2001
- Fundamental
- Price
- PGRE $6.35
- OMCL $28.03
- Analyst Decision
- PGRE Hold
- OMCL Buy
- Analyst Count
- PGRE 4
- OMCL 6
- Target Price
- PGRE $5.38
- OMCL $44.83
- AVG Volume (30 Days)
- PGRE 2.3M
- OMCL 572.4K
- Earning Date
- PGRE 07-30-2025
- OMCL 07-31-2025
- Dividend Yield
- PGRE 0.55%
- OMCL N/A
- EPS Growth
- PGRE N/A
- OMCL N/A
- EPS
- PGRE N/A
- OMCL 0.45
- Revenue
- PGRE $711,729,000.00
- OMCL $1,135,755,000.00
- Revenue This Year
- PGRE $1.66
- OMCL $3.84
- Revenue Next Year
- PGRE N/A
- OMCL $4.07
- P/E Ratio
- PGRE N/A
- OMCL $61.89
- Revenue Growth
- PGRE 49.28
- OMCL 3.00
- 52 Week Low
- PGRE $3.75
- OMCL $22.66
- 52 Week High
- PGRE $6.62
- OMCL $55.75
- Technical
- Relative Strength Index (RSI)
- PGRE 66.88
- OMCL 39.02
- Support Level
- PGRE $6.31
- OMCL $30.73
- Resistance Level
- PGRE $6.62
- OMCL $32.05
- Average True Range (ATR)
- PGRE 0.15
- OMCL 0.76
- MACD
- PGRE -0.06
- OMCL -0.26
- Stochastic Oscillator
- PGRE 60.38
- OMCL 0.99
About PGRE Paramount Group Inc.
Paramount Group Inc is a real estate investment trust engaged in owning, operating, managing, acquiring, and redeveloping high-quality, Class A office properties in select central business district (CBD) submarkets of New York City and San Francisco. The company operates in two geographical segments New York and San Francisco. The company derives nearly all of its majority of revenue from rental income.
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.